Alexium International Group
Dr. Paul Stenson BSc (Science), PhD (Chemistry) has had a distinguished career with the research, development, manufacture, and commercialization of new materials. Dr. Stenson is currently President and CEO of StanChem Inc., comprising of two companies – StanChem Polymers, and Albi Protective Coatings. Dr Stenson has over 20 years of experience in senior management positions in the polymer and chemicals industry. Dr. Stenson is also the chairman of TopChem Pharmaceuticals (Ireland) which is a manufacturer of active pharmaceutical ingredients.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Alexium International Group
Alexium International Group Limited is engaged in conducting research and development on technology, licensing its intellectual properties and selling its specialized chemistry to customers. The Company is also engaged in the development and licensing of its flame retardant (FR) chemicals and reactive surface treatment (RST) technologies. The Company's products include Alexiflam FR, which is an FR for synthetic and synthetic-blend fabrics; Alexiflam SYN, which is an FR solution designed for the textile and resin markets; Alexiflam NF, which is an FR treatment for cotton and cotton-blends; Alexicool, which is a chemical finish for fabrics that absorb heat; Alexiflam PB, which is a halogenated FR, and Alexiflam AD, which is a combination of synergistic flame-retardants for treatment of a range of fabric blends and constructions. The Company markets its products to defense, automotive and transportation, outdoor, home furnishings, and plastics and resins industries.